JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111216200 on January 16, 2002

J. Biol. Chem., Vol. 277, Issue 15, 13294-13301, April 12, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/15/13294    most recent
M111216200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kröncke, K.-D.
Right arrow Articles by Sies, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kröncke, K.-D.
Right arrow Articles by Sies, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Comparing Nitrosative Versus Oxidative Stress toward Zinc Finger-dependent Transcription

UNIQUE ROLE FOR NO*

Klaus-Dietrich KrönckeDagger §, Lars-Oliver Klotz, Christoph V. SuschekDagger , and Helmut Sies||

From the Dagger  Research Group Immunobiology of the Biomedical Research Center and the  Institute of Physiological Chemistry I, Medical Department of the Heinrich-Heine-University, D-40225 Düsseldorf, Germany

Received for publication, November 26, 2001, and in revised form, January 15, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

During inflammatory reactions, cells are under nitrosative and/or oxidative stress. The zinc finger transcription factors vitamin D receptor (VDR) and retinoid X receptor (RXR) were used as a model system to characterize effects of NO· and/or reactive oxygen species on zinc finger-dependent gene expression. Nitric oxide (NO·) as well as H2O2, singlet oxygen (1O2), peroxyl radicals (ROO·), and peroxynitrite (ONOO-), respectively, were shown to inhibit VDR/RXR-DNA complex formation in vitro in a dose-dependent manner. While NO-induced inhibition of VDR/RXR-DNA complex formation could be restored nearly completely by subsequent treatment with dithiothreitol, inhibition by H2O2 proved to be only partially reversible, and inhibition by 1O2, ROO· or ONOO- was found to be irreversible. In cells transiently transfected with VDR and RXR, subtoxic concentrations of NO· or hydroperoxides and intracellular generation of superoxide anion radicals inhibited VDR/RXR-dependent reporter gene activity in a dose-dependent manner. Interestingly, cells can repair the zinc fingers of VDR and RXR after nitrosative stress but not after oxidative stress. The results indicate that, among the reactive species investigated, only NO· may act sufficiently gentle to be considered as a regulator and not only as an inhibitor of gene expression via zinc finger transcription factors.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effects of nitric oxide (NO·) on cellular functions are complex and even appear to be contradictory, janus-headed. NO· may act cytotoxically but may also protect cells from toxic insults (1), it may compromise the cellular redox state but may also act as an antioxidant (2, 3), and it may activate or inhibit signal transduction pathways (4, 5) and gene transcription (6-9), respectively. Many of these effects can, at least in part, be explained by different NO· concentrations achieved in the respective microenvironment. Nanomolar concentrations of NO·, as typically synthesized in a tightly regulated fashion by constitutively expressed nitric oxide synthase (cNOS),1 serve as a signal molecule activating the soluble guanylate cyclase to produce cGMP, which acts as a second messenger. However, in addition to two cNOS there is also an inducible NOS (iNOS) expressed in a variety of acute or chronic disease states (for reviews see Refs. 10, 11). Originally described as a cytotoxic activated macrophage effector molecule (12) it is now evident that iNOS-derived NO· exerts a multitude of biological functions. In an apparently unregulated fashion iNOS synthesizes NO· for hours or even days resulting in micromolar concentrations of NO·. Under these conditions NO· may react with oxygen in a reaction mainly depending on the NO· concentration to yield higher nitrogen oxides (NOx such as N2O3, etc.), which display a much broader chemical reaction spectrum than NO· itself (13).

A growing body of evidence suggests that NO· after reaction to NOx helps to orchestrate gene expression, e.g. via posttranslational modifications of transcription factors. A prevalent DNA binding motif of transcription factors is the zinc finger structure with Zn2+ tetrahedrally coordinated between a beta -hairpin and a short alpha -helix, creating a small, functional and independently folded domain (14). In these zinc fingers cysteine thiols and histidine imidazole nitrogens serve as direct ligands for the zinc ion.

We previously found that NO· S-nitrosates cysteines in metallothionein, mediating the release of Zn2+ from this zinc-storing protein (15), induces Zn2+ release within cells (16) and is able to inhibit zinc finger-dependent transcription (17-19). However, zinc fingers can easily be disrupted by cysteine oxidation, e.g. by reactive oxygen species, or by electrophilic attack, e.g. by alkylating compounds (for reviews see Refs. 20, 21). The question therefore arises, whether the reaction of NO· with zinc fingers may have a special role, different from the reaction with other reactive species generated during inflammatory reactions. Such species are superoxide, its dismutation product hydrogen peroxide, the product of its reaction with NO·, peroxynitrite, or singlet oxygen, as well as peroxyl radicals.

To investigate the impact of these species on the zinc finger integrity, we used the transcription factors VDR and RXR as a model system both containing two Cys4-type zinc fingers, which bind to specific promoter sequences as the heterodimeric complex VDR/RXR. VDR/RXR-DNA complex formation was quantified after treatment of VDR/RXR with reactive oxygen and nitrogen oxide species in vitro. In addition, VDR/RXR-dependent reporter gene activity was investigated in living cells after treatment with NO· or reactive oxygen species. Our results demonstrate that, among the reactive species investigated, NO· shows unique characteristics with a potential role in gene regulation.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Materials-- The NO-donors MAMA/NO ((Z)-1-{N-methyl-N-[6-(N-methylammoniohexyl)amino]}diazen-1-ium-1,2-diolate), and DETA/NO ((Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate) were synthesized as described (22). Peroxynitrite (ONOO-) was synthesized by reaction of H2O2 with isoamyl nitrite (Sigma) on ice at pH 12.5 (23). Contaminating isoamyl alcohol was removed by intense washing with chloroform (23), and unreacted H2O2 was removed by reaction with MnO2 (24). The resulting solution was adjusted to pH 14, and the concentration of peroxynitrite was determined spectroscopically at 302 nm (epsilon  = 1670 M-1 cm-1) (25). Stock solutions were stored at -80 °C for several months without loss of absorbance. Degraded ONOO- (ONOO<UP><SUB>deg</SUB><SUP>−</SUP></UP>) was obtained after neutralization of a 6-mM ONOO- stock solution with HCl and incubation for 2 h at 37 °C. The singlet oxygen generator disodium 3,3'-(1,4-naphthylidene) dipropionate 1,4-endoperoxide (NDPO2) was synthesized as described (26-28). Decomposed endoperoxide (NDPO2deg), verified spectroscopically as NDP (28), was obtained by incubating a 50-mM stock solution of NDPO2 for 2 days at 37 °C. Hydrogen peroxide and tert-butyl hydroperoxide (t-BHP) were purchased from Merck, 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) was purchased from Alexis (Grünberg, Germany), 2,2-azobis-(2-amidinopropane) dihydrochloride (AAPH) was purchased from Polysciences (Warrington, PA), and 1alpha ,25-dihydroxyvitamin D3 (VD) was kindly provided by Dr. L. Binderup (Leo Pharmaceutical Products, Ballerup, Denmark).

Gel Shift Assays-- Human VDR and human RXRalpha cDNA were subcloned into the pSG5 expression vector (Stratagene, Heidelberg, Germany) (29). Linearized cDNA from VDR and RXR, respectively, were transcribed with T7 RNA polymerase and translated using wheat germ lysate as recommended by the supplier (Promega, Mannheim, Germany). Similar amounts of in vitro translated VDR and RXR proteins were mixed and incubated in the presence or absence of 1 µM VD for 15 min at room temperature in a total volume of 20 µl of binding buffer (10 mM Hepes, pH 7.9, 100 mM KCl, 0.2 µg/µl poly[d(I-C)] and 5% glycerol). Indicated amounts of MAMA/NO, H2O2, NDPO2, AAPH or ONOO- were added, and the mixtures were incubated for various times. The DR3-type VD response element (VDRE) of the rat ANF gene promoter (30) (core sequence AGAGGTCATGAAGGACA) was labeled by a fill-in reaction using [alpha -32P]dCTP and the Klenow fragment of DNA polymerase I (Promega). Approximately 1 ng of labeled probe (50,000 cpm) was added to the receptor-ligand mixture, and incubation was continued for 30 min at room temperature. Protein-DNA complexes were resolved on 8% nondenaturing polyacrylamide gels at room temperature in 0.5 × TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA, pH 8.3). The gels were dried and exposed to a Fuji MP2040S imager screen overnight. The ratio of free probe to protein-probe complexes was quantified with a Fuji FLA2000 reader using Image Gauge software (Fuji, Tokyo, Japan).

Transfection and Reporter Gene Assay-- MCF-7 (human breast adenocarcinoma) cells obtained from ATCC (Manassas, VA) were seeded into 6-well plates (3 × 105 cells/well) and grown overnight in RPMI 1640 supplemented with 10% charcoal-treated fetal calf serum. Liposomes were formed by incubating 0.25 µg of the expression vectors for VDR and for RXR each plus 1 µg of the reporter gene constructs (four copies of the rat ANF DR3-type VDRE fused to the tk promotor driving the luciferase reporter gene) with 15 µg of N-[1-(2,3-dioleoyloxy)propyl]-N, N,N-trimethylammonium methylsulfate (Roth, Karlsruhe, Germany) for 15 min in a total volume of 100 µl of H2O. After dilution with 0.9 ml of RPMI 1640, the liposomes were added to the cells that had been prewashed with phosphate-buffered saline. The transfection medium was removed after 5 h, and 1 ml of RPMI 1640/10% fetal calf serum was added. After a further 8 h 0.5 ml of RPMI 1640 containing 10% fetal calf serum plus 100 nM VD or the solvent control (0.1% ethanol) together with the indicated concentrations of DETA/NO, H2O2, t-BHP, or DMNQ were added. The cells were lysed 8 h after the onset of VD stimulation using a reporter gene assay lysis buffer (Roche Molecular Biochemicals, Mannheim, Germany), and a constant-light-signal luciferase reporter gene assay was performed using LucLiteTMPlus (Canberra-Packard, Dreieich, Germany). The luciferase activities were normalized to the protein content determined by the method of Bradford (31), and induction was calculated as the ratio of luciferase activity of VD-stimulated cells to that of solvent controls.

Semiquantitative Reverse Transcription (RT)-PCR-- Total cellular RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and the RNase-free DNase Set (Qiagen) exactly as described by the manufacturer and was used (1 µg of RNA each) for cDNA synthesis (32). RT was carried out at 37 °C for 1 h using the Omniscript RT Kit and oligo(dT)16 primers (Qiagen). PCR was performed with this cDNA using the Taq PCR Core Kit (Qiagen) and primers for luciferase (Photinus pyralis) cDNA (GenBankTM accession number X84848); sense: 5'-ATTGCTTTTACAGATGCACA-3' (bases 232-251), antisense: 5'-TAGGATCTCTGGCATGCGAG-3' (bases 771-790). Expression of the housekeeping gene GAPDH was analyzed using primers for GAPDH cDNA (GenBankTM accession number M17851); sense: 5'-ATGCCCGATGGCACCATCAGA-3' (bases 153-175), antisense: 5'-TCTCCAGGCCCATCCTCCTGC-3' (bases 548-568). PCR was carried out following standard procedures (33). To ensure that amplification conditions were within the linear phase, PCR was performed using various numbers of cycles with RNA isolated from transfected and VD-stimulated cells. The following cycle profiles were found to be suitable: 20 cycles at 94 °C/30 s, 56 °C/60 s, and 72 °C/60 s for luciferase mRNA amplification, and 18 cycles at 94 °C/30 s, 58 °C/30 s, and 72 °C/30 s for GAPDH mRNA amplification, respectively. As a control, PCR was performed with all additives but without cDNA or with all additives but only with RNA, respectively, to exclude unspecific amplifications. Equal amounts of DNA were electrophoresed on a 1.8% agarose gel. The luciferase/GAPDH ratio was obtained by densitometric analysis of ethidium bromide-visualized amplification product bands using the Kodak 1D software (Kodak, Stuttgart, Germany).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In VitroStudies-- To investigate effects of nitrosative and/or oxidative stress toward zinc finger transcription factors, in vitro translated VDR and RXR proteins were used as a model system. VDR-RXR heterodimers (VDR/RXR) were incubated with various concentrations of NO· or reactive oxygen species before analyzing VDR/RXR-DNA complex formation to the DR3-type VDRE of the rat ANF gene promoter by gel shift experiments.

Nitric Oxide-- NO· was generated by decomposition of the NO-donor MAMA/NO (half-life at 37 °C: 2 min). Fig. 1A shows that NO· generated by MAMA/NO inhibits VDR/RXR-DNA complex formation in a concentration-dependent manner with an IC50 value of about 0.5 mM MAMA/NO. Using preformed VDR/RXR-VDRE complexes as targets, MAMA/NO with a nearly identical IC50 value (about 0.4 mM) induced the release of VDR/RXR from its response element (Fig. 1B). The DNA complex formation of MAMA/NO-treated VDR/RXR was nearly completely restored by subsequent incubation with 1 or 10 mM dithiothreitol (DTT) for 30 min at 30 °C (Fig. 1C). To investigate whether NO· affects the response element as well, VDRE was preincubated with up to 5 mM MAMA/NO for 30 min at 30 °C before VDR/RXR was added. A significant inhibition was observed only with the highest NO-donor concentration (Fig. 1D).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of NO· on VDR/RXR-DNA complex formation in vitro. Gel shift experiments were performed using in vitro translated VDR and RXR and the DR3-type VDRE of the rat ANF gene. Treatment of (A) free or (B) already VDRE-bound VDR/RXR with MAMA/NO for 30 min at 30 °C resulted in a concentration-dependent inhibition of VDR/RXR-DNA complex formation. C, subsequent addition of 1-10 mM DTT for 30 min at 30 °C nearly completely reversed the inhibitory effect of MAMA/NO. D, treatment of VDRE with MAMA/NO before addition of VDR/RXR resulted in a partial inhibition of VDR/RXR-DNA complex formation at high MAMA/NO concentrations. Representative gels are shown. Relative complex formation is presented in reference to the control in the absence of MAMA/NO. Columns represent means ± standard deviation of at least three independent experiments.

Hydrogen Peroxide-- Incubating VDR/RXR with increasing concentrations of H2O2 for 90 min at 30 °C provided a significant inhibition of the VDR/RXR-DNA complex formation only at relatively high H2O2 concentrations (>20 mM) with an IC50 value of 40-50 mM H2O2 (Fig. 2A). Similar high H2O2 concentrations were needed to release DNA-bound VDR/RXR from its response element (Fig. 2B). Subsequent incubation with 10-20 mM DTT showed partial restoration of the VDR/RXR-DNA complex formation (Fig. 2C). DTT has been reported to complex zinc ions (34), but even high DTT concentrations (20 mM) apparently did not lead to ejection of Zn2+ from the zinc fingers as the DNA binding activity of VDR/RXR was not affected by treatment with DTT alone (Fig. 2C). Pretreatment of the VDRE with H2O2 prior to addition of VDR/RXR showed similar IC50 values with regard to the formation of VDR/RXR-DNA complexes compared with VDR/RXR (Fig. 2D).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of H2O2 on VDR/RXR-DNA complex formation in vitro. Gel shift experiments were performed as described in the legend of Fig. 1. Treatment of free (A) or already VDRE-bound (B) VDR/RXR with H2O2 for 90 min at 30 °C resulted in a concentration-dependent inhibition of the VDR/RXR-DNA complex formation. C, subsequent addition of 10-20 mM DTT for 30 min at 30 °C partially reversed the inhibitory effect of H2O2 on VDR/RXR-DNA complex formation. D, treatment of VDRE with H2O2 before addition of VDR/RXR plus 50 mM DTT to protect VDR/RXR from residual H2O2 resulted in a concentration-dependent inhibition of VDR/RXR-DNA complex formation. Representative gels are shown. Relative complex formation is presented in reference to the control in the absence of H2O2. Columns represent means ± standard deviation of at least three independent experiments.

Singlet Oxygen-- Singlet oxygen (1O2) was generated by decomposition of NDPO2 (half-life at 37 °C: 23 min) leading to the formation of NDP and molecular oxygen with a 1O2 yield of 50% (28, 35). Incubating VDR/RXR with increasing concentrations of NDPO2 for 90 min at 30 °C resulted in a concentration-dependent inhibition of the VDR/RXR-DNA complex formation with an IC50 value of about 0.75 mM NDPO2, while the decomposition product NDPO2deg showed no effects (Fig. 3A). Already DNA-bound VDR/RXR were found to be slightly more sensitive to NDPO2 (IC50 about 0.4 mM) compared with unbound VDR/RXR (Fig. 3B). Subsequent incubation with up to 20 mM DTT for 30 min at 30 °C did not restore the VDR/RXR-DNA complex formation (Fig. 3C). Experiments using 10 mM of the 1O2 quencher sodium azide revealed partial protection from the effects of 5 mM NDPO2 indicating that indeed 1O2 was the effective compound in our system (Fig. 3D). Pretreatment of the VDRE with NDPO2 induced inhibition of subsequent VDR/RXR-DNA complex formation with an IC50 value of about 4 mM NDPO2 (Fig. 3E). This is in line with the capability of 1O2 to oxidatively modify DNA (36).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of 1O2 on VDR/RXR-DNA complex formation in vitro. Gel shift experiments were performed as described in the legend of Fig. 1. Treatment of free (A) or already VDRE-bound (B) VDR/RXR with the singlet oxygen generator NDPO2 for 90 min at 30 °C resulted in a concentration-dependent inhibition of the VDR/RXR-DNA complex formation, while degraded NDPO2 (NDPO2deg) had no effect. C, subsequent addition of up to 20 mM DTT for 30 min at 30 °C did not restore VDR/RXR-DNA complex formation. D, treatment of VDR/RXR with NDPO2 in the presence of 10 mM of the 1O2 quencher sodium azide resulted in a partial protection of VDR/RXR showing that indeed 1O2 was the active compound. E, treatment of VDRE with NDPO2 before addition of VDR/RXR plus 50 mM DTT to protect VDR/RXR from residual-generated 1O2 resulted in a concentration-dependent inhibition of VDR/RXR-DNA complex formation. Representative gels are shown. Relative complex formation is presented in reference to the control in the absence of NDPO2. Columns represent means ± standard deviation of at least three independent experiments.

Peroxyl Radicals-- Peroxyl radicals (ROO·) were generated by decomposition of AAPH (half-life at 37 °C about 175 h) forming carbon-centered radicals that react swiftly with O2 to yield ROO· (37). Incubating VDR/RXR with increasing concentrations of AAPH for 2 h at 30 °C resulted in a concentration-dependent inhibition of the VDR/RXR-DNA complex formation with an IC50 value of about 10 mM AAPH (Fig. 4A). DNA-bound VDR/RXR was found to be slightly more sensitive toward treatment with AAPH (IC50 value of about 7 mM) than unbound VDR/RXR (Fig. 4B). Subsequent treatment with up to 20 mM DTT for 30 min at 30 °C did not restore VDR/RXR-DNA complex formation (Fig. 4C). Pretreatment of the VDRE with AAPH prior to addition of VDR/RXR resulted in an IC50 value for VDR/RXR-DNA complex formation of ~7 mM AAPH (Fig. 4D).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of peroxyl radicals on VDR/RXR-DNA complex formation in vitro. Gel shift experiments were performed as described in the legend of Fig. 1. Treatment of free (A) or already VDRE-bound (B) VDR/RXR with the peroxyl radical generator AAPH for 2 h at 30 °C resulted in a concentration-dependent inhibition of the VDR/RXR-DNA complex formation. C, subsequent addition of up to 20 mM DTT for 30 min at 30 °C did not restore VDR/RXR-DNA complex formation. D, treatment of VDRE with AAPH before addition of VDR/RXR plus 50 mM DTT to protect VDR/RXR from residual-generated peroxyl radicals resulted in a concentration-dependent inhibition of VDR/RXR-DNA complex formation. Representative gels are shown. Relative complex formation is presented in reference to the control in the absence of AAPH. Columns represent means ± standard deviation of at least three independent experiments.

Peroxynitrite-- NO· and the superoxide anion radical react to form the strong oxidant peroxynitrite anion (ONOO-), which has a half-life of about 1 s under physiological conditions (24). We used chemically synthesized authentic ONOO- as a source. Prior to use, the 260 mM ONOO- stock solution was diluted with ice-cold deionized H2O to a ONOO- concentration of 6 mM. To avoid pH changes resulting from the use of up to 2 mM ONOO- diluted from the 6 mM ONOO- stock solution, 200 mM phosphate buffer was employed. This buffer had no effect on the VDR/RXR-DNA complex formation (not shown). Incubating VDR/RXR with increasing concentrations of ONOO- for 10 min at room temperature resulted in a concentration-dependent inhibition of the VDR/RXR-DNA complex formation with an IC50 value in the range of about 0.3-0.4 mM ONOO- (Fig. 5A). Adding VDR/RXR various times after the addition of ONOO- showed that inhibition of the VDR/RXR-DNA complex formation occurred within 10 s (data not shown). Addition of multiple low ONOO- doses (5 × 0.2 mM every minute) did not result in a shift of the IC50 value for ONOO- (not shown). DNA-bound VDR/RXR were slightly more sensitive toward treatment with ONOO- (IC50 value of ~0.3 mM) than unbound VDR/RXR (Fig. 5B). Subsequent treatment with up to 20 mM DTT for 30 min at 30 °C did not restore the VDR/RXR-DNA complex formation (Fig. 5C). Addition of 20 mM methionine nearly completely inhibited the inhibitory effect of 1 mM ONOO- (Fig. 5D). Pretreatment of the VDRE with up to 5 mM ONOO- had no effect on VDR/RXR-DNA complex formation (Fig. 5E). Higher concentrations of ONOO- could not be used due to problems with the pH and the salt concentration essential for optimal VDR/RXR-DNA complex formation.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of ONOO- on VDR/RXR-DNA complex formation in vitro. Gel shift experiments were performed as described in the legend in Fig. 1. Treatment of free (A) or already VDRE-bound (B) VDR/RXR with authentic ONOO- for 10 min at room temperature resulted in a concentration-dependent inhibition of the VDR/RXR-DNA complex formation, while degraded ONOO- (ONOO<UP><SUB>deg</SUB><SUP>−</SUP></UP>) had no effect. C, subsequent addition of up to 20 mM DTT for 30 min at 30 °C did not restore VDR/RXR-DNA complex formation. D, treatment of VDR/RXR with ONOO- in the presence of 20 mM methionine resulted in a significant protection of VDR/RXR-DNA complex formation. E, treatment of VDRE with up to 5 mM ONOO- before addition of VDR/RXR showed no inhibitory effect on the VDR/RXR-DNA complex formation. Representative gels are shown. Relative complex formation is presented in reference to the control in the absence of ONOO-. Columns represent means ± standard deviation of at least three independent experiments.

Studies with Living Cells-- To investigate whether the results found in vitro are also found with cells, MCF-7 cells were transiently transfected with expression vectors for VDR and RXR, respectively, and a luciferase reporter gene plasmid under the control of four copies of the rat ANF DR3-type VDRE (30). To avoid effects of NO or reactive oxygen species on the protein expression values, the cells were allowed to recover after transfection for 8 h and to overexpress inactive VDR and RXR, respectively. Cells were then stimulated with 100 nM VD or solvent (0.1% ethanol) for various time intervals. Subsequent determination of the luciferase activity revealed that VD activated the reporter gene time dependently in a linear fashion: 2 h, 6.1 ± 0.6-fold; 4 h, 25.8 ± 2.7-fold; 6 h, 49.1 ± 4.9-fold; 8 h, 79.6 ± 4.8-fold; 10 h, 98.5 ± 6.6-fold; 24 h, 288.8 ± 22.6-fold (n = 3). To investigate effects of NO· or reactive oxygen species on VDR/RXR-dependent transcription, the 8 h time period was chosen for further experiments. Only those concentrations of the various compounds were used that proved to be subtoxic (>= 95% cell viability investigated by morphological analysis and trypan blue exclusion after 12 h compared with untreated controls).

Nitric Oxide-- To investigate effects of NO· on VDR/RXR-dependent transcription we used DETA/NO, an NO-donor similar to MAMA/NO but with a considerably longer half-life (about 8 h at 37 °C). Increasing DETA/NO concentrations inhibited VD-stimulated luciferase activity with an IC50 value of about 100 µM DETA/NO (Fig. 6A). In contrast, 1 mM of the control compound DETA had no effect (97.2 ± 4.1% of control) showing that indeed NO· was the effective compound.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of NO·, peroxides, or intracellular O<UP><SUB><B>2</B></SUB><SUP><B>&cjs1138;</B></SUP></UP> generation on VDR/RXR-dependent reporter gene activity. MCF-7 cells were transiently transfected with expression vectors for VDR and RXR, respectively, together with a luciferase reporter gene plasmid under the control of four copies of the rat ANF DR3-type VDRE. After 8 h recovery and synthesis of inactive VDR/RXR, cells were stimulated with 100 nM VD or solvent (0.1% ethanol) in the presence of various concentrations of DETA/NO (A), H2O2 (B), t-BHP (C), or the intracellular O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generator DMNQ (D). Luciferase activity normalized to the cellular protein content was quantified after 8 h, and stimulation was calculated as the ratio of luciferase activity of VD-stimulated cells to the luciferase activity of solvent controls. All compounds investigated inhibited VDR/RXR-dependent reporter gene activity in a concentration-dependent manner. Data represent means ± standard deviation of at least three independent experiments.

Hydroperoxides-- The transfected cells were incubated with increasing concentrations of hydroperoxides. H2O2 induced a concentration-dependent inhibition of VD-stimulated luciferase activity with an IC50 value of about 300 µM H2O2 (Fig. 6B). t-BHP also induced a concentration-dependent inhibition of the reporter gene activity with an IC50 value of about 45 µM t-BHP (Fig. 6C).

Intracellular Superoxide-- As source for intracellular O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation we used the redox cycler DMNQ. Fig. 6D shows that DMNQ inhibited VDR/RXR-dependent luciferase activity in a concentration-dependent manner with an IC50 value of about 5 µM DMNQ.

Reversibility-- To ask whether the observed effects on zinc finger-dependent transcription in cells are reversible, the transiently transfected cells were treated with the IC50 value concentrations of DETA/NO, H2O2, t-BHP, or DMNQ for 8 h. After a recovery period of 5 h in fresh medium, cells were stimulated with 100 nM VD or solvent vehicle for another 8 h. After treatment with 100 µM DETA/NO, 50 µM t-BHP, or 5 µM DMNQ, cells could again be stimulated by VD for reporter gene activity (about 80% restored activity compared with non-pretreated controls). After treatment with 300 µM H2O2, however, cells were refractory to stimulation with VD (Fig. 7).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 7.   Reversibility of the inhibitory effects of NO·, peroxides, or intracellular O<UP><SUB><B>2</B></SUB><SUP><B>&cjs1138;</B></SUP></UP> generation on VDR/RXR-dependent reporter gene activity. MCF-7 cells were transiently transfected as described in the legend of Fig. 6. After 8 h recovery and synthesis of inactive VDR/RXR, cells were incubated with (empty bars) or without (black bars) 100 nM VD or solvent (0.1% ethanol) and treated for an additional 8 h with the IC50 value concentrations of DETA/NO, H2O2, t-BHP or the intracellular O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generator DMNQ. Cells cultured without VD (black bars) were then incubated in fresh medium for 5 h to recover from nitrosative or oxidative stress and were subsequently stimulated with 100 nM VD or solvent (0.1% ethanol) for additional 8 h. Luciferase activity normalized to the cellular protein content was quantified, and stimulation was calculated as the ratio of luciferase activity of VD-stimulated cells to the luciferase activity of solvent controls. While the inhibitory effects of NO·, t-BHP, and DMNQ, respectively, were reversible, the effect of H2O2 proved to be irreversible. Data represent means ± standard deviation of three independent experiments.

With this experimental design it was not possible to discriminate whether the disrupted zinc finger transcription factors were repaired by the cells or whether they were synthesized de novo. Therefore, transiently transfected cells were treated for 8 h with the IC50 value concentrations of DETA/NO, H2O2, t-BHP, or DMNQ, and were then stimulated with 100 nM VD or solvent vehicle in the presence of the translational inhibitor cycloheximide. Treatment with 10 µg/ml cycloheximide inhibited VD-stimulated luciferase activity by 96.3 ± 2.6% (n = 3). RNA was isolated after 15 h, and RT-PCR was performed to quantitate VDR/RXR-dependent luciferase mRNA expression. Fig. 8 shows that VD stimulated luciferase mRNA expression about 7-fold compared with unstimulated cells. Interestingly, even in the presence of cycloheximide a pretreatment of the cells with 100 µM DETA/NO for 8 h still allowed full stimulation of VDR/RXR-dependent luciferase mRNA expression by VD (Fig. 8, lane 4). In contrast, pretreatment with 300 µM H2O2, 50 µM t-BHP, or 5 µM DMNQ allowed for subsequent significant VD-stimulated luciferase mRNA expression (Fig. 8, lanes 5-7). These results demonstrate that cells are able to repair VDR/RXR after nitrosative stress but not after oxidative stress.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 8.   Cells repair VDR/RXR after nitrosative but not after oxidative stress. MCF-7 cells were transiently transfected as described in the legend of Fig. 6. After 8 h of recovery and synthesis of inactive VDR/RXR, cells were incubated in the absence (lanes 1-3) or presence of 100 µM DETA/NO (lane 4), 300 µM H2O2 (lane 5), 50 µM t-BHP; (lane 6), or 5 µM of the intracellular O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generator DMNQ (lane 7) for 8 h. Cells were then treated without (lane 2) or with 100 nM VD (lanes 1 and 3-7) or solvent (0.1% ethanol, lane 2) in the presence of 10 µg/ml cycloheximide (CHX) to inhibit de novo synthesis of VDR and RXR. After 15 h, total cellular RNA was isolated and luciferase- and GAPDH-specific RT-PCR was performed. Under these conditions, VDR/RXR-dependent luciferase mRNA expression was not affected after nitrosative stress, while after oxidative stress luciferase mRNA expression was significantly inhibited. Values are means ± standard deviation of three independent experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In Vitro-- Nitric oxide is able to nitrosate cysteine thiols in proteins yielding S-nitrosothiols under aerobic conditions, probably via formation of N2O3 (13, 38). In the case of zinc fingers, which contain up to four cysteines, this reaction leads to the ejection of the zinc ion (15, 39, 40). However, various sulfhydryl-oxidizing compounds such as H2O2 (41-46), O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> (47), ONOO- (48), HOCl (45, 48), or diamide (46, 49), as well as sulfhydryl-alkylating compounds, such as iodoacetamide (43, 46) or N-ethylmaleimide (43, 50), have also been shown to disrupt zinc-sulfur complexes in various proteins.

To investigate whether effects of nitrosative and oxidative stress, respectively, differ with regard to zinc finger-dependent transcription factors, we treated VDR/RXR with compounds that are generated under conditions of nitrosative and/or oxidative stress, i.e. NO·, H2O2, 1O2, ROO·, or ONOO-. All these compounds inhibited the DNA complex formation and thus the DNA binding activity of VDR/RXR in a concentration-dependent manner (Figs. 1A-5A). The millimolar range of the IC50 value for H2O2 appears to be rather high but fits with concentrations reported for the inhibition of other zinc finger transcription factors, such as the glucocorticoid receptor (41, 42, 51), Sp1 (43, 44), or the estrogen receptor (49). Prebinding to its response element did not protect VDR/RXR from the inhibitory effects (Figs. 1B-5B). In contrast, we found equal or in some cases even slightly enhanced sensitivity of prebound VDR/RXR to our treatment regimens as compared with pretreating VDR/RXR before DNA binding. This suggests that the zinc fingers within the protein-DNA complex are equally or even slightly more accessible for the reactive species investigated. From a functional point of view this means that reactive species are able to inhibit zinc finger-dependent gene expression during all phases of their action.

NO-induced inhibition of VDR/RXR-DNA complex formation was nearly completely restored by subsequent reduction with DTT (Fig. 1C). After treatment with H2O2, DTT was able to partially (about 50%) restore the DNA complex formation of VDR/RXR (Fig. 2C). In contrast, treatment with 1O2, ROO·, or ONOO- led to irreversible loss of the DNA binding activity of VDR/RXR since DTT did not restore VDR/RXR-DNA complex formation (Figs. 3C-5C). This suggests that H2O2, 1O2, ROO·, or ONOO- at least partially oxidize zinc finger cysteine thiols (Cys-SH) beyond the level of disulfides, e.g. to sulfinic (Cys-SO2H), sulfonic acid (Cys-SO3H) (21), or even thiosulfinate (Cys-SO-S-Cys) (52). Among the amino acids present in proteins only cysteines are modified by NO· (53), while the other reactive species used in this study are able to modify additional amino acids in proteins also, e.g. to oxidize methionine to methionine sulfoxide (49, 54) or, in the case of ONOO-, to nitrate tyrosine (55, 56). VDR and RXR each contain 17 methionine residues, which in part are located close to the zinc finger domains, and RXR even contains four tyrosines within or nearby the DNA binding domain. All these amino acid modifications may contribute to inhibition of the VDR/RXR-DNA complex formation by H2O2, 1O2, ROO·, or ONOO-.

The reactive species NO·, H2O2, 1O2, and ROO· were found to affect in a dose-dependent manner the VDRE such that subsequently added VDR/RXR were unable to bind anymore. Interestingly, the ratios of the IC50 values found for VDRE and for VDR/RXR were calculated as >10 for NO·, ~1 for H2O2, 10 for 1O2, ~1 for ROO·, and >10 for ONOO-. This provides NO· with an unique profile among the studied reactive species, as the disruption of zinc fingers by NO· is reversible and a more than 10-fold higher NO· concentration is needed to half-maximally inactivate the VDRE compared with VDR/RXR.

Cells-- Using living cells, we investigated whether effects of nitrosative stress on VDR/RXR-dependent transcription differ from effects of oxidative stress. Transiently transfected cells were treated with subtoxic concentrations of the NO-donor DETA/NO, the two hydroperoxides H2O2 and tert-butyl hydroperoxide, and the redox cycler DMNQ, which generates O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> intracellularly. The 1O2 generator NDPO2 could not be used as degraded NDPO2 for unknown reasons showed a strong inhibitory effect on VDR/RXR-dependent luciferase reporter gene activity (data not shown). All compounds investigated inhibited the VDR/RXR-dependent luciferase activity in a concentration-dependent manner (Fig. 6). The IC50 value found using t-BHP was about 7-fold lower than the IC50 value found for H2O2. This may be due to several cellular depletion pathways for H2O2 (e.g. glutathione peroxidase, catalase) and/or the direction of the hydrophobic t-BHP to more hydrophobic cellular compartments than H2O2. The IC50 value found for H2O2 in vitro (40-50 mM) and that found in living cells (300 µM) differed considerably. However, differences of two orders of magnitude have also been reported using the zinc finger transcription factor glucocorticoid receptor (51).

In living cells reversibility of the inhibition of VDR/RXR-DNA complex formation was shown after exposure to NO·, t-BHP, or DMNQ at concentrations corresponding to the IC50 values (Fig. 7). In contrast, after treatment with H2O2 no reversibility was found, although the H2O2 concentration used (300 µM) also proved to be nontoxic. This suggests that in addition to VDR/RXR-dependent transcription additional cellular functions are affected by H2O2.

To investigate whether cells are able to repair disrupted VDR/RXR, we treated cells with the reactive species and then stimulated them with VD in the presence of the translational inhibitor cycloheximide, which inhibited de novo synthesis of VDR/RXR. Results showed that after exposure to NO· VDR/RXR-dependent luciferase mRNA expression was unaffected (Fig. 8). In contrast, exposure to the hydroperoxides or DMNQ resulted in significantly impaired expression of luciferase mRNA. These results suggest that cells are able to repair S-nitrosated zinc finger transcription factors, whereas oxidative modifications appear to be irreversible.

Although in this study only transcription factors containing Cys4-type zinc fingers were investigated, experiments using the Cys2/His2-type zinc finger transcription factor Sp1 have shown, that the latter is also very susceptible toward H2O2 (43, 44) and NO· (17, 19), respectively. As all known zinc finger structures contain at least two cysteine residues (14) and as the cysteine thiols are the redox-sensitive parts of zinc fingers it is highly likely that our results can be generalized with regard to all zinc-finger containing transcription factors. Whether nitrosative or oxidative stress also affects the translocation of zinc finger transcription factors into the nucleus remains to be determined.

In conclusion, we suggest that the more gentle reactions of NO· permit cells to handle nitrosation of zinc finger transcription factors with minimal collateral damage as hypothesized recently (57) compared with the irreversible modifications induced by oxidative stress. Thus, NO· is not just another compound able to destroy zinc finger domains of proteins but may potentially serve as a gene regulatory molecule during inflammatory reactions.

    ACKNOWLEDGEMENTS

We thank Dr. C. Carlberg for many helpful discussions, Dr. M. Macias-Gonzalez for help with the gel shift experiments, and U. Lammersen for skilled technical assistance.

    FOOTNOTES

* This study was supported by Grant SFB 503, B1 from the Deutsche Forschungsgemeinschaft.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Research Group Immunobiology, Bldg. 23.12, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany. Tel.: 49-211-81-13188; Fax: 49-211-15027; E-mail: kroencke@uni-duesseldorf.de.

|| Fellow of the National Foundation for Cancer Research, Bethesda, MD.

Published, JBC Papers in Press, January 16, 2002, DOI 10.1074/jbc.M111216200

    ABBREVIATIONS

The abbreviations used are: cNOS, constitutive nitric oxide synthase; iNOS, inducible nitric oxide synthase; VDR, 1alpha ,25-dihydroxyvitamin D3 receptor; RXR, retinoid X receptor; MAMA/NO, (Z)-1-{N-methyl-N-[6-(N-methylammoniohexyl)amino]}diazen-1-ium-1,2-diolate; DETA/NO (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1, 2-diolate; NDPO2, 3,3'-(1,4-naphthylidene)dipropionate 1,4-endoperoxide; t-BHP, tert-butyl hydroperoxide; DMNQ, 2,3-dimethoxy-1,4-naphthoquinone; AAPH, 2,2-azobis-(2-amidinopropane); VD, 1alpha ,25-dihydroxyvitamin D3; VDRE, 1alpha ,25-dihydroxyvitamin D3 response element; RT, reverse transcription; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; DTT, dithiothreitol.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Kim, P. K. M., Zamora, R., Petrosko, P., and Billiar, T. R. (2001) Int. Immunopharmacol. 1, 1421-1441[CrossRef][Medline] [Order article via Infotrieve]
2. Kröncke, K. D., Suschek, C. V., and Kolb-Bachofen, V. (2000) Antiox. Redox Signal. 2, 585-605[CrossRef][Medline] [Order article via Infotrieve]
3. O'Donnell, V. B., and Freeman, B. A. (2001) Circ. Res. 88, 12-21[Abstract/Free Full Text]
4. Beck, K. F., Eberhardt, W., Frank, S., Huwiler, A., Messmer, U. K., Mühl, H., and Pfeilschifter, J. (1999) J. Exp. Biol. 202, 645-653[Abstract]
5. Schindler, H., and Bogdan, C. (2001) Int. Immunopharmacol. 1, 1443-1455[CrossRef][Medline] [Order article via Infotrieve]
6. Marshall, H. E., Merchant, K., and Stamler, J. S. (2000) FASEB J. 14, 1889-1900[Abstract/Free Full Text]
7. Bogdan, C. (2001) Trends Cell Biol. 11, 66-75[CrossRef][Medline] [Order article via Infotrieve]
8. Pfeilschifter, J., Eberhardt, W., and Beck, K. F. (2001) Eur. J. Physiol. 442, 479-486[CrossRef][Medline] [Order article via Infotrieve]
9. Kröncke, K. D. (2001) Antiox. Redox Signal. 3, 565-575[CrossRef][Medline] [Order article via Infotrieve]
10. Kröncke, K. D., Fehsel, K., and Kolb-Bachofen, V. (1998) Clin. Exp. Immunol. 113, 147-156[CrossRef][Medline] [Order article via Infotrieve]
11. Zamora, R., Vodovotz, Y., and Billiar, T. R. (2000) Mol. Med. 6, 347-373[Medline] [Order article via Infotrieve]
12. Hibbs, J. B., Taintor, R. R., Vavrin, Z., and Rachlin, E. M. (1988) Biochem. Biophys. Res. Commun. 157, 87-94[CrossRef][Medline] [Order article via Infotrieve]
13. Wink, D. A., and Mitchell, J. B. (1998) Free Radic. Biol. Med. 25, 434-456[CrossRef][Medline] [Order article via Infotrieve]
14. Klug, A., and Schwabe, J. W. R. (1995) FASEB J. 9, 597-604[Abstract]
15. Kröncke, K. D., Fehsel, K., Schmidt, T., Zenke, F. T., Dasting, I., Wesener, J. R., Bettermann, H., Breunig, K. D., and Kolb-Bachofen, V. (1994) Biochem. Biophys. Res. Commun. 200, 1105-1110[CrossRef][Medline] [Order article via Infotrieve]
16. Berendji, D., Kolb-Bachofen, V., Meyer, K. L., Grapenthin, O., Weber, H., Wahn, V., and Kröncke, K. D. (1997) FEBS Lett. 405, 37-41[CrossRef][Medline] [Order article via Infotrieve]
17. Berendji, D., Kolb-Bachofen, V., Zipfel, P. F., Skerka, C., Carlberg, C., and Kröncke, K. D. (1999) Mol. Med. 5, 721-730[Medline] [Order article via Infotrieve]
18. Kröncke, K. D., and Carlberg, C. (2000) FASEB J. 14, 166-173[Abstract/Free Full Text]
19. Berendji-Grün, D., Kolb-Bachofen, V., and Kröncke, K. D. (2001) Mol. Med. 7, 745-754
20. Webster, K. A., Prentice, H., and Bishopric, N. H. (2001) Antiox. Redox Signal. 3, 535-548[CrossRef][Medline] [Order article via Infotrieve]
21. Wilcox, D. E., Schenk, A. D., Feldman, B. M., and Xu, Y. (2001) Antiox. Redox Signal. 3, 549-564[CrossRef][Medline] [Order article via Infotrieve]
22. Hrabie, J. A., Klose, J. R., Wink, D. A., and Keefer, L. K. (1993) J. Org. Chem. 58, 1472-1476[CrossRef]
23. Uppu, R. M., and Pryor, W. A. (1996) Anal. Biochem. 236, 242-249[CrossRef][Medline] [Order article via Infotrieve]
24. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1620-1624[Abstract/Free Full Text]
25. Hughes, M. N., and Nicklin, H. G. (1968) J. Chem. Soc. (Lond.) 450-452
26. Nieuwint, A. W. M., Aubry, J. M., Arwert, F., Kortbeek, H., Herzog, S., and Joenje, H. (1985) Free Radic. Res. Commun. 1, 1-9[Medline] [Order article via Infotrieve]
27. Aubry, J. M. (1985) J. Am. Chem. Soc. 107, 5844-5849
28. DiMascio, P., and Sies, H. (1989) J. Am. Chem. Soc. 111, 2909-2914[CrossRef]
29. Carlberg, C., Bendik, I., Wyss, A., Meier, E., Sturzenbecker, L. J., Grippo, J. F., and Hunzicker, W. (1993) Nature 361, 657-660[CrossRef][Medline] [Order article via Infotrieve]
30. Kahlen, J. P., and Carlberg, C. (1996) Biochem. Biophys. Res. Commun. 218, 882-886[CrossRef][Medline] [Order article via Infotrieve]
31. Bradford, M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
32. Gubler, W., and Hoffman, B. (1983) Gene 25, 263-269[CrossRef][Medline] [Order article via Infotrieve]
33. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A. (1988) Science 239, 487-491[Abstract/Free Full Text]
34. Cornell, N. W., and Crivaro, K. E. (1972) Anal. Biochem. 47, 203-208[CrossRef][Medline] [Order article via Infotrieve]
35. Pierlot, C., Hajjam, S., Barthélémy, C., and Aubry, M. (1996) J. Photochem. Photobiol. B Biol. 36, 31-39
36. Sies, H., and Menck, C. F. (1992) Mutat. Res. 275, 367-375[CrossRef][Medline] [Order article via Infotrieve]
37. Niki, E. (1990) Methods Enzymol. 186, 100-108[CrossRef][Medline] [Order article via Infotrieve]
38. Broillet, M. C. (1999) Cell. Mol. Life Sci. 55, 1036-1042[CrossRef][Medline] [Order article via Infotrieve]
39. Zangger, K., Öz, G., Haslinger, E., Kunert, O., and Armitage, I. M. (2001) FASEB J. 15, 1303-1305[Free Full Text]
40. Kröncke, K. D., Haase, H., Kolb-Bachofen, V., Beyersmann, D., and Hayer-Hartl, M. K. (2001) Nitric Oxide Biol. Chem. 5, 289-295[CrossRef][Medline] [Order article via Infotrieve]
41. Tienrungroj, W., Meshinchi, S., Sanchez, E. R., Pratt, S. E., Grippo, J. F., Holmgren, A., and Pratt, W. B. (1987) J. Biol. Chem. 262, 6992-7000[Abstract/Free Full Text]
42. Hutchison, K. A., Matic, G., Meshinchi, S., Breshnick, E. H., and Pratt, W. B. (1991) J. Biol. Chem. 266, 10505-10509[Abstract/Free Full Text]
43. Knoepfel, L., Steinkühler, C., Carrí, M. T., and Rotilio, G. (1994) Biochem. Biophys. Res. Commun. 201, 871-877[CrossRef][Medline] [Order article via Infotrieve]
44. Ammendola, R., Mesuraca, M., Russo, T., and Cimino, F. (1994) Eur. J. Biochem. 225, 483-489[Medline] [Order article via Infotrieve]
45. Casadevall, M., and Sarkar, B. (1998) J. Inorg. Biochem. 71, 147-152[CrossRef][Medline] [Order article via Infotrieve]
46. Liang, X., Lu, B., Scott, G. K., Chang, C. H., Baldwin, M. A., and Benz, C. C. (1998) Mol. Cell. Endocrinol. 146, 151-161[CrossRef][Medline] [Order article via Infotrieve]
47. Knapp, L. T., and Klann, E. (2000) J. Biol. Chem. 275, 24136-24145[Abstract/Free Full Text]
48. Crow, J. P., Beckman, J. S., and McCord, J. M. (1995) Biochemistry 34, 3544-3552[CrossRef][Medline] [Order article via Infotrieve]
49. Whittal, R. M., Benz, C. C., Scott, G., Semyonov, J., Burlingame, A. L., and Baldwin, M. A. (2000) Biochemistry 39, 8406-8417[CrossRef][Medline] [Order article via Infotrieve]
50. Hayashi, S. I., Hajiro-Nakanishi, K., Makino, Y., Eguchi, H., Yodoi, J., and Tanaka, H. (1997) Nucleic Acids Res. 25, 4035-4040[Abstract/Free Full Text]
51. Esposito, F., Cuccovillo, F., Morra, F., Russo, T., and Cimino, F. (1995) Biochim. Biophys. Acta 1260, 308-314[Medline] [Order article via Infotrieve]
52. Xu, Y., and Wilcox, D. E. (1998) J. Am. Chem. Soc. 120, 7375-7376[CrossRef]
53. Wink, D. A., Nims, R. W., Darbyshire, J. F., Christodoulou, D., Hanbauer, I., Cox, G. W., Laval, F., Cook, J. A., Krishna, M. C., DeGraff, W. G., and Mitchell, J. B. (1994) Chem. Res. Toxicol. 7, 519-525[CrossRef][Medline] [Order article via Infotrieve]
54. Levine, R. L., Mosoni, L., Berlett, B. S., and Stadtman, E. R. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 15036-15040[Abstract/Free Full Text]
55. Beckman, J. S., Ischiropoulos, H., Zhu, L., van der Woerd, M., Smith, C., Chen, J., Harrison, J., Martin, J. C., and Tsai, M. (1992) Arch. Biochem. Biophys. 298, 438-445[CrossRef][Medline] [Order article via Infotrieve]
56. Ohshima, H., Friesen, M., Brouet, I., and Bartsch, H. (1990) Food Chem. Toxicol. 28, 647-652[CrossRef][Medline] [Order article via Infotrieve]
57. Kröncke, K. D. (2001) FASEB J. 15, 2503-2507[Abstract/Free Full Text]


Copyright © 2002 by The Amer